• Aucun résultat trouvé

Melanoma of skin

N/A
N/A
Info
Télécharger
Protected

Academic year: 2022

Partager "Melanoma of skin"

Copied!
2
0
0

Chargement.... (Voir le texte intégral maintenant)

Texte intégral

(1)Melanoma of skin Source: Globocan 2020. Number of new cases in 2020, both sexes, all ages Breast Lung Colorectum Prostate Stomach Liver Cervix uteri Oesophagus Thyroid Bladder Non-Hodgkin lymphoma Pancreas Leukaemia Kidney Corpus uteri Lip, oral cavity Melanoma of skin Ovary Brain, central nervous system Larynx Multiple myeloma Nasopharynx Gallbladder Oropharynx Hypopharynx Hodgkin lymphoma Testis Salivary glands Vulva Penis Kaposi sarcoma Mesothelioma Vagina. 604 127 604 100 586 202 573 278 544 352 495 773 474 519 431 288 417 367 377 713 324 635 313 959 308 102 184 615 176 404 133 354 115 949 98 412 84 254 83 087 74 458 53 583 45 240 36 068 34 270 30 870 17 908. 0. 500 000. 1 089 103 905 677. 1 000 000. Number of deaths in 2020, both sexes, all ages. 2 261 419 2 206 771 1 931 590. 1 414 259. 1 500 000. Lung Colorectum Liver Stomach Breast Oesophagus Pancreas Prostate Cervix uteri Leukaemia Non-Hodgkin lymphoma Brain, central nervous system Bladder Ovary Kidney Lip, oral cavity Multiple myeloma Larynx Corpus uteri Gallbladder Nasopharynx Melanoma of skin Oropharynx Thyroid Hypopharynx Mesothelioma Hodgkin lymphoma Salivary glands Vulva Kaposi sarcoma Penis Testis Vagina. 2 000 000. 1 796 144. 935 173 830 180 768 793 684 996 544 076 466 003 375 304 341 831 311 594 259 793 251 329 212 536 207 252 179 368 177 757 117 077 99 840 97 370 84 695 80 008 57 043 48 143 43 646 38 599 26 278 23 376 22 778 17 427 15 086 13 211 9 334 7 995. 0. 500 000. 1 000 000. 1 500 000. Cancer incidence and mortality statistics worldwide and by region Incidence Both sexes. Mortality. Males. New cases. Cum. risk 0-74 (%). Middle Africa Northern Africa Southern Africa Western Africa. 2 056 1 099 968 1 885 955. Caribbean Central America South America. Females. New cases. Cum. risk 0-74 (%). 0.10 0.19 0.05 0.36 0.06. 735 593 478 968 337. 414 2 452 16 015. 0.07 0.15 0.29. Northern America. 105 172. Eastern Asia South-Eastern Asia South-Central Asia Western Asia. 10 427 3 275 6 232 3 819. Central and Eastern Europe Western Europe Southern Europe Northern Europe. Both sexes. New cases. Cum. risk 0-74 (%). 0.07 0.23 0.05 0.45 0.04. 1 321 506 490 917 618. 232 1 199 7 802. 0.09 0.16 0.32. 1.76. 61 675. 0.04 0.05 0.04 0.17. 5 414 1 742 3 312 1 922. 27 993 65 168 23 915 33 551. 0.62 1.99 0.93 1.91. Australia and New Zealand Melanesia Polynesia Micronesia. 18 972 240 27 0. Low HDI Medium HDI High HDI Very high HDI World. Males. Deaths. Cum. risk 0-74 (%). 0.12 0.15 0.05 0.29 0.07. 856 469 429 517 408. 182 1 253 8 213. 0.06 0.13 0.27. 2.06. 43 497. 0.05 0.06 0.04 0.18. 5 013 1 533 2 920 1 897. 12 191 34 745 12 436 16 937. 0.65 2.11 0.99 1.92. 3.96 0.33 0.42 0. 11 003 109 14 0. 3 728 7 121 35 597 277 993. 0.09 0.04 0.10 1.12. 324 635. 0.37. Eastern Africa. Deaths. Deaths. Cum. risk 0-74 (%). 0.04 0.08 0.02 0.10 0.02. 305 255 205 288 140. 0.03 0.10 0.02 0.13 0.02. 551 214 224 229 268. 0.05 0.07 0.02 0.08 0.03. 179 959 4 519. 0.03 0.05 0.08. 105 564 2 546. 0.04 0.07 0.10. 74 395 1 973. 0.02 0.04 0.06. 1.50. 8 412. 0.12. 5 443. 0.16. 2 969. 0.08. 0.04 0.05 0.03 0.16. 5 436 1 616 3 579 1 355. 0.02 0.03 0.02 0.05. 2 917 848 2 004 807. 0.02 0.03 0.02 0.07. 2 519 768 1 575 548. 0.02 0.02 0.02 0.04. 15 802 30 423 11 479 16 614. 0.60 1.89 0.88 1.91. 9 272 7 415 4 926 4 747. 0.18 0.16 0.15 0.20. 4 614 4 300 2 977 2 814. 0.23 0.20 0.20 0.26. 4 658 3 115 1 949 1 933. 0.15 0.12 0.10 0.15. 4.67 0.28 0.47 0. 7 969 131 13 0. 3.29 0.38 0.38 0. 1 880 64 5 0. 0.27 0.08 0.10 0. 1 212 37 4 0. 0.36 0.08 0.14 0. 668 27 1 0. 0.18 0.08 0.05 0. 1 538 3 629 17 517 151 055. 0.08 0.04 0.10 1.25. 2 190 3 492 18 080 126 938. 0.09 0.04 0.09 1.02. 1 647 3 863 13 167 38 352. 0.04 0.02 0.04 0.13. 686 2 085 7 255 22 351. 0.04 0.02 0.04 0.16. 961 1 778 5 912 16 001. 0.04 0.02 0.03 0.09. 173 844. 0.42. 150 791. 0.33. 57 043. 0.06. 32 385. 0.07. 24 658. 0.05. Incidence, both sexes. Mortality, both sexes. LAC** (5.8%). 5-year prevalence, both sexes. Africa (4.7%). Oceania (5.9%). Europe (46.4%). Asia (7.3%) N.America* (32.4%). LAC** (5.1%). LAC** (9.9%). Oceania (6.2%). Europe (46.2%). N.America* (14.7%). Number. Europe (47.3%). Asia (6.2%) N.America* (33.7%). Asia (21%). Population. Females. Cum. risk 0-74 (%). Population. Number. Population. Number. Europe *Northern America. 150 627 105 172. Europe Asia. 26 360 11 986. Europe *Northern America. 517 196 368 049. Asia Oceania. 23 753 19 239. *Northern America **Latin America and the Caribbean. 8 412 5 657. Asia Oceania. 68 197 68 070. **Latin America and the Caribbean Africa Total. 18 881 6 963 324 635. Africa Oceania Total. 2 679 1 949 57 043. **Latin America and the Caribbean Africa Total. 55 663 15 643 1 092 818. The Global Cancer Observatory - All Rights Reserved, December, 2020.. Page 1.

(2) Age standardized (World) incidence rates, melanoma of skin, males, all ages. ≥ 7.3 2.4–7.3 0.94–2.4 0.52–0.94 0.29–0.52 < 0.29. Not applicable No data. Age standardized (World) incidence rates, melanoma of skin, females, all ages. ≥ 6.2 2.6–6.2 1.00–2.6 0.55–1.00 0.28–0.55 < 0.28. Not applicable No data. Data source: GLOBOCAN 2020 Graph production: IARC (https://gco.iarc.fr/today) World Health Organization. © International Agency for Research on Cancer 2020. Age standardized (World) incidence rates, melanoma of skin, by sex Males Australia and New Zealand Western Europe Northern America Northern Europe Southern Europe Central and Eastern Europe Southern Africa Polynesia World South America Melanesia Middle Africa Western Asia Central America Caribbean Eastern Africa South-Eastern Asia Northern Africa Eastern Asia South-Central Asia Western Africa Micronesia. Females. 41.6. Incidence Australia and New Zealand Western Europe Northern Europe Northern America Southern Europe Central and Eastern Europe Polynesia World Southern Africa Melanesia South America Western Asia Middle Africa Central America Eastern Africa Caribbean Western Africa South-Eastern Asia Northern Africa Eastern Asia South-Central Asia Micronesia. 30.5 19.4. 18.9. 18.5. 14.3. 17.4. 18.4 9.2. 8.9. 5.7. 5.6. 4.1. 2.8. 3.9. 3.6. 3.8. 3.0. 3.1. 2.7. 3.0. 3.4. 1.7. 60. Age standardized (World) incidence and mortality rates, melanoma of skin. 40. 20. 1.2. 1.6. 1.5. 1.4. 1.2. 0.85. 0.57. 0.71. 1.1. 0.53. 0.40. 0.47. 0.44. 0.42. 0.37. 0.36. 0.31. 0.35. 0.60. 0. 20. ASR (World) per 100 000 The Global Cancer Observatory - All Rights Reserved, December, 2020.. 40. 60. Mortality. 35.8. 2.7 18.9. 1.5. 17.8. 1.9. 16.1. 1.1 9.0. 1.4. 5.6. 1.7. 3.7. 0.74. 3.4. 0.56. 3.3. 0.93. 3.2. 0.91. 2.9. 0.79. 1.5. 60. 50. 40. 30. 20. 0.54. 1.4. 0.64. 1.3. 0.49. 0.92. 0.40. 0.70. 0.28. 0.48. 0.22. 10. 0.46. 0.23. 0.45. 0.20. 0.39. 0.19. 0.33. 0.19. 0. 10. 20. 30. 40. 50. 60. ASR (World) per 100 000 Page 2.

(3)

Références

Télécharger maintenant ( PDF - 2 Page - 0.93 MB )

Documents relatifs

Observations and regional modeling of aerosol optical properties, speciation and size distribution over Northern Africa and western Europe

Results are presented with N the number of daily mean available measurements for the period from 10 June to 30 July 2013, the temporal correlation (R t ), the root mean square

Decision Support Software for Melanoma Skin Cancer Detection (DECIME)

Although the Multilayer Perceptron classifier offers a better solu- tion from the data obtained by the Central Moments extractor, the authors perceive similar results from the

Vulnerabilities in Central and Eastern Europe : Credit Growth

In this work, we try to analyze the recent credit development in 11 Central and Eastern European countries and estimate the credit-to-GDP ratio equilibrium level using

L'HIFU guidé par l'IRM et la radiothérapie : quel avenir ? : travail de Bachelor

Pour un tel traitement il faut plusieurs appareils : le HIFU pour l’émission des ultrasons par le biais de transducteurs, un générateur pour fournir la puissance nécessaire

Introduction : Savoirs profanes, savoirs scientifiques dans la formation des enseignants

Les savoirs d’action sont légitimes dès lors qu’ils sont identifiés comme permettant de développer les individus, les collectifs de travail, les organisations et qu’ils

Skin Lesion Analysis Towards Melanoma Detection for ISIC 2018

In this paper we briefly discuss our methods for addressing Task 1 (lesion segmentation), Task 2 (lesion attribute detection) and Task 3 (classification) of the ISIC 2018 Competition

Constitutive activation of the ERK pathway in melanoma and skin melanocytes in Grey horses

Given the importance of the MAPK/ERK pathway activation in melanoma development, we examined the levels of the activated (phosphorylated) ERK1/2 (P-ERK1/2) in primary cutaneous

Spectral degree of linear polarization of light from healthy skin and melanoma

While healthy skin exhibits a near flat spectral DOLP with a value around 0.2, all the cancerous samples show higher values with a decrease of their DOLP in the infrared region.